Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more ...
On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
Breathing machines with adaptive servo-ventilation (ASV) did not improve survival or other clinical outcomes in patients with heart failure (HF) and reduced ejection fraction and sleep-disordered ...
There's a problem though. CPAP doesn't seem to improve CVD-related outcomes. In some cases, it's even harmful. Let's do a quick review. In 2005, the CANPAP study found CPAP didn't improve a composite ...
Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by pauses in respiratory effort related to an unstable ventilatory system. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results